RVX-20

N/A

Report date: 2025/04/15 11:46:00

Base Information

Drug NameRVX-20
Drug Alias NameRVX-20
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMultiple SclerosisEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRocketVax AG
China Registration ClassN/A

Develop Information

Active CompaniesRocketVax AG
Inactive CompaniesN/A
Active IndicationsMultiple SclerosisEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A